מטוג'קט 50 מ"ג / מ"ל

Kraj: Izrael

Język: hebrajski

Źródło: Ministry of Health

Składnik aktywny:

METHOTREXATE 50 MG/ML

Dostępny od:

TZAMAL BIO-PHARMA LTD

Kod ATC:

L01BA01

Forma farmaceutyczna:

SOLUTION FOR INJECTION

Droga podania:

S.C, I.M, I.V

Wyprodukowano przez:

MEDAC GESELLSCHAFT FUER KLIN.SPEZIAL.mbh

Grupa terapeutyczna:

METHOTREXATE

Wskazania:

Psoriasis:because of the high risk attending its use, Methotrexate is indicated only in the symptomatic control of severe recalcitrant, disabling psoriasis which is not adequately responsive to other forms of therapy, and only when the diagnosis has been established, as by biopsy and/or after dermatological consultation. Rheumatoid Arthritis: Methotrexate can be used in the treatment of selected adults with severe rheumatoid arthritis, only when the diagnosis has been well estabished according to rheumatological standards, with inadequate response to other forms of antirheumatic therapy, including full dose NSAIDs and usually a trial of at least one or more disease-modifying antirheumatic drugs.Juvenile Idiopathic Arthritis:Treatment of Polyarthritic forms of severe, active juvenile idiopathic arthritis when the response to non-steroidal anti-inflammatory drugs (NSAIDs) has been inadequate

Data autoryzacji:

2011-02-01